Early Phase Study Design and Clinical Development Strategy Consultants

Optimise early phase clinical studies, generate certainty & secure the most favourable path to market

We offer expert partnering and consultation to ensure your early phase clinical studies and development strategy incorporates modern best practices to effectively generate data that will satisfy all external decision makers and your commercialization targets. Our services build confidence that your early phase studies and program will reliably and effectively meet your vital clinical development needs

MORE ABOUT US
What we Offer

Customized solutions for early phase clinical study design and clinical development strategy

When you access Armstrong Clinical you leverage the expertise of professionals in Early Phase Study Design, Translational Medicine, Phase I-IV development strategy, pricing and market access and study implementation. Before your first study begins, define your path to market with early phase study design that assure subsequent clinical development decisions

Clinical Development: Path to Market

Before your studies begin, we help you define the regulatory strategy, clinical study requirements, commercial expectation cost and time requirements at each stage of development. This allows for effective decision making and and a clear path to market

Phase I and IIa Study Designs

We work with you to design or review your planned early phase clinical studies. Our experience designing simple to modern, complex early phase studies will help taylor a design to suit your therapy, indication and company objectives.

Study Location and CRO Selection

Looking to conduct your early phase in Australia? It’s important the CRO and Clinical Site best suited to your organisation, disease are and project. is selected. We can help advise where best to conduct your early phase study and with who.

Clinical Development of Today

Tools and techniques of study design and development strategy are evolving rapidly to generate more efficient studies, programs and precision outcomes. Understand when and how complex adaptive designs, predictive modelling, etc. can be utilised to create precision and reduce your development time and cost.

What we bring to the table

We add value across the clinical development lifecycle from Phase I studies through to Phase IV. Some key skills that our team brings to the table include:

SOUND REGULATORY INSIGHTS
TRIAL PLANNING & DESIGN
GATED TARGET PLANNING
UNDERSTAND COMPLEXITY
EXECUTION & LOCATION ADVICE
WRITING, PUBLISHING & SUBMISSIONS

Exploring our services for your project?

Client Testimonials

Don’t take our word for it – here’s what our clients say:

“Our engagement with Armstrong Clinical has been extremely valuable. The advice was pragmatic and provided us with a range of options based on our objectives, timelines and budget. The stage-gated approach to developing our clinical development strategy provided clarity and metrics that are unique to our program and will guide our decision-making process.”

Dr Rachel de las Heras – Program Director 

Queensland Brain Institute, University of Queensland 

“Armstrong Clinical provided top-notch assistance with our clinical development program. Their advice regarding our early phase clinical trial helped us meet our development timelines.”

John – Sr. Director

Large Multinational Pharma

Latest Blog Posts

At Armstrong Clinical we are committed to providing our audience latest information about various aspects of clinical development, especially as it applies in the Australian context. 

“Haplomind” Big data analytics, Biology and Machine Learning to help treat Perinatal Depression.

We sit down with Haplomind founder Dr. Sonali Mohanty Quantius to understand more about Haplomind and its use in the treatment of Post-Partum Mental Health Data analytics and machine learning[…]

Read more

Brad Joblin from Armstrong Clinical invited as Guest Speaker to the AGM of the HSP Research Foundation

Bradley Joblin from Armstrong Clinical has been invited to be the guest speaker at the AGM of HSP Research Foundation. Hereditary Spastic Paraplegia (HSP) is a rare degenerative neurological disorder[…]

Read more

Agreement Between Armstrong Clinical and MyMedical to Provide Comprehensive Clinical Trial, Clinical Development and Commercial Support Services to Biotech, Medtech and Pharmaceutical Industry Clients.

Melbourne (Australia) – 4th August 2020: Armstrong Clinical, specialists in clinical development strategy, early phase clinical study design, pricing and regulatory strategy is pleased to announce it has entered into an agreement[…]

Read more

Contact Us

If you need any information about our services and how our team can add value to your project, please feel free to contact us. We would be glad to discuss further.

Click Here for Contact Details